Table 2 Baseline characteristics and virological test results of RSV positive children in Italy (n = 119) and the Netherlands (n = 12)
Italy | Netherlands | ||||
|---|---|---|---|---|---|
Total (n = 119) | 1–12 months (n = 53) | 13–24 months (n = 26) | 2–4 years (n = 40) | Total (n = 12) | |
Boys | 59 (50%) | 30 (57%) | 13 (50%) | 16 (40%) | 9 (75%) |
Age in months median (IQR) | 15 (7–30) | 6 (4–9) | 20 (15–21) | 35 (30–46) | 11 (8–15) |
Symptoms | |||||
Cough | 117 (98%) | 52 (98%) | 26 (100%) | 39 (98%) | 10 (83%) |
Coryza | 106 (89%) | 46 (87%) | 26 (100%) | 34 (85%) | 8 (67%) |
Shortness of breath | 89 (76%) | 45 (87%) | 15 (60%) | 29 (73%) | 6 (50%) |
Sore throat | 36 (30%) | 16 (30%) | 10 (38%) | 10 (25%) | 0 |
Medical historya | |||||
Prematurity | 6 (5%) | 0 | 4 (15%) | 2 (5%) | 1 (8%) |
Other chronic medical condition | 2 (2%) | 0 | 0 | 2 (5%) | 0 |
Chronic respiratory disease | 1 (1%) | 0 | 0 | 1 (3%) | 0 |
Malnutrition | 0 | 0 | 0 | 0 | 1 (8%) |
Virological test results | |||||
RSV A | 91 (76%) | 40 (75%) | 21 (81%) | 30 (75%) | 9 (75%) |
RSV B | 28 (24%) | 13 (25%) | 5 (19%) | 10 (25%) | 3 (25%) |